Work

TE-1146, a novel anti-CD38-antibody-lenalidomide conjugate, demonstrates potent ex vivo anti-myeloma activity

Year: 2025
Type: article
Abstract: Not available.
Language: English
Subfield: Hematology
Field: Medicine
Open Access status: gold
Estimated APC paid: $2,157
OpenAlex ID: W4415952029
FWCI:
Cites:
Cited by:
Related to: